悦安新材(688786) - 2022 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2022 was CNY 103,698,599.68, representing a year-on-year increase of 34.92%[5] - The net profit attributable to shareholders for the same period was CNY 26,985,917.82, reflecting a growth of 63.51% compared to the previous year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 21,042,406.90, an increase of 46.06% year-on-year[5] - The basic and diluted earnings per share for Q1 2022 were both CNY 0.32, an increase of 23.08% compared to the same period last year[5] - The operating profit for Q1 2022 was 31,990,459.65 CNY, compared to 19,285,090.22 CNY in Q1 2021, indicating an increase of approximately 65.73%[20] - The company reported a total comprehensive income of 27,717,594.91 CNY for Q1 2022, compared to 17,412,488.93 CNY in Q1 2021, reflecting an increase of approximately 59.00%[21] Cash Flow and Investments - The net cash flow from operating activities was CNY 24,804,720.54, showing a decrease of 8.93% compared to the same period last year[5] - The company reported a net cash outflow from investing activities of -28,973,005.46 CNY in Q1 2022, compared to -10,506,472.18 CNY in Q1 2021[24] - The cash and cash equivalents at the end of Q1 2022 totaled 221,395,577.85 CNY, a decrease from 43,256,388.58 CNY at the end of Q1 2021[24] Assets and Liabilities - The total assets at the end of the reporting period were CNY 796,332,742.48, which is a 5.84% increase from the end of the previous year[6] - Current assets as of March 31, 2022, totaled RMB 575,195,877.26, up from RMB 552,352,673.80 at the end of 2021, reflecting a growth of approximately 4%[16] - Total liabilities as of March 31, 2022, were RMB 153,704,240.76, compared to RMB 137,687,602.32 at the end of 2021, indicating an increase of approximately 11.6%[18] - Non-current liabilities rose to RMB 68,410,497.58 from RMB 57,988,520.09, reflecting an increase of around 17.4%[18] - The company's retained earnings increased to RMB 183,445,407.82 from RMB 156,459,490.00, showing a growth of approximately 17.3%[18] Research and Development - The company's R&D investment totaled CNY 5,063,750.74, down 15.54% year-on-year, with R&D expenses accounting for 4.88% of operating revenue[6] - The company incurred research and development expenses of 5,063,750.74 CNY in Q1 2022, compared to 5,995,374.21 CNY in Q1 2021, indicating a decrease of about 15.56%[20] Market Strategy - The company reported a net profit margin improvement due to increased revenue and effective cost management strategies[19] - The company plans to focus on expanding its market presence and investing in new product development in the upcoming quarters[19] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 4,396[12]